1 Study Coverage 1.1 Lymphocyte Activation Gene 3 Protein Product Introduction 1.2 Market by Type 1.2.1 Global Lymphocyte Activation Gene 3 Protein Market Size Growth Rate by Type 1.4.2 BMS-986016 1.4.3 ENUM-006 1.2.4 IKT-203 1.2.5 IMP-701 1.2.6 Others 1.3 Market by Application 1.3.1 Global Lymphocyte Activation Gene 3 Protein Market Size Growth Rate by Application 1.3.2 Chronic Inflammation 1.3.3 Head and Neck Cancer Squamous Cell Carcinoma 1.3.4 Kidney Cancer 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lymphocyte Activation Gene 3 Protein Sales Estimates and Forecasts 2016-2027 2.2 Global Lymphocyte Activation Gene 3 Protein Revenue Estimates and Forecasts 2016-2027 2.3 Global Lymphocyte Activation Gene 3 Protein Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Lymphocyte Activation Gene 3 Protein Regions by Sales 2.4.1 Global Top Lymphocyte Activation Gene 3 Protein Regions by Sales (2016-2021) 2.4.2 Global Top Lymphocyte Activation Gene 3 Protein Regions by Sales (2022-2027) 2.5 Global Top Lymphocyte Activation Gene 3 Protein Regions by Revenue 2.5.1 Global Top Lymphocyte Activation Gene 3 Protein Regions by Revenue (2016-2021) 2.5.2 Global Top Lymphocyte Activation Gene 3 Protein Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Lymphocyte Activation Gene 3 Protein Sales by Manufacturers 3.1.1 Global Top Lymphocyte Activation Gene 3 Protein Manufacturers by Sales (2016-2021) 3.1.2 Global Top Lymphocyte Activation Gene 3 Protein Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Lymphocyte Activation Gene 3 Protein Sales in 2020 3.2 Global Lymphocyte Activation Gene 3 Protein Revenue by Manufacturers 3.2.1 Global Top Lymphocyte Activation Gene 3 Protein Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Lymphocyte Activation Gene 3 Protein Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Lymphocyte Activation Gene 3 Protein Revenue in 2020 3.3 Global Lymphocyte Activation Gene 3 Protein Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Lymphocyte Activation Gene 3 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Lymphocyte Activation Gene 3 Protein Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Lymphocyte Activation Gene 3 Protein Sales by Type 4.1.1 Global Lymphocyte Activation Gene 3 Protein Historical Sales by Type (2016-2021) 4.1.2 Global Lymphocyte Activation Gene 3 Protein Forecasted Sales by Type (2022-2027) 4.1.3 Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) 4.2 Global Lymphocyte Activation Gene 3 Protein Revenue by Type 4.2.1 Global Lymphocyte Activation Gene 3 Protein Historical Revenue by Type (2016-2021) 4.2.2 Global Lymphocyte Activation Gene 3 Protein Forecasted Revenue by Type (2022-2027) 4.2.3 Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) 4.3 Global Lymphocyte Activation Gene 3 Protein Price by Type 4.3.1 Global Lymphocyte Activation Gene 3 Protein Price by Type (2016-2021) 4.3.2 Global Lymphocyte Activation Gene 3 Protein Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Lymphocyte Activation Gene 3 Protein Sales by Application 5.1.1 Global Lymphocyte Activation Gene 3 Protein Historical Sales by Application (2016-2021) 5.1.2 Global Lymphocyte Activation Gene 3 Protein Forecasted Sales by Application (2022-2027) 5.1.3 Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) 5.2 Global Lymphocyte Activation Gene 3 Protein Revenue by Application 5.2.1 Global Lymphocyte Activation Gene 3 Protein Historical Revenue by Application (2016-2021) 5.2.2 Global Lymphocyte Activation Gene 3 Protein Forecasted Revenue by Application (2022-2027) 5.2.3 Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) 5.3 Global Lymphocyte Activation Gene 3 Protein Price by Application 5.3.1 Global Lymphocyte Activation Gene 3 Protein Price by Application (2016-2021) 5.3.2 Global Lymphocyte Activation Gene 3 Protein Price Forecast by Application (2022-2027) 6 North America 6.1 North America Lymphocyte Activation Gene 3 Protein Market Size by Type 6.1.1 North America Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2027) 6.1.2 North America Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2027) 6.2 North America Lymphocyte Activation Gene 3 Protein Market Size by Application 6.2.1 North America Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2027) 6.2.2 North America Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2027) 6.3 North America Lymphocyte Activation Gene 3 Protein Market Size by Country 6.3.1 North America Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2027) 6.3.2 North America Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Lymphocyte Activation Gene 3 Protein Market Size by Type 7.1.1 Europe Lymphocyte Activation Gene 3 Protein Sales by Type (2017-2027) 7.1.2 Europe Lymphocyte Activation Gene 3 Protein Revenue by Type (2017-2027) 7.2 Europe Lymphocyte Activation Gene 3 Protein Market Size by Application 7.2.1 Europe Lymphocyte Activation Gene 3 Protein Sales by Application (2017-2027) 7.2.2 Europe Lymphocyte Activation Gene 3 Protein Revenue by Application (2017-2027) 7.3 Europe Lymphocyte Activation Gene 3 Protein Market Size by Country 7.3.1 Europe Lymphocyte Activation Gene 3 Protein Sales by Country (2017-2027) 7.3.2 Europe Lymphocyte Activation Gene 3 Protein Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Lymphocyte Activation Gene 3 Protein Market Size by Type 8.1.1 Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Type (2018-2027) 8.1.2 Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Type (2018-2027) 8.2 Asia Pacific Lymphocyte Activation Gene 3 Protein Market Size by Application 8.2.1 Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Application (2018-2027) 8.2.2 Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Application (2018-2027) 8.3 Asia Pacific Lymphocyte Activation Gene 3 Protein Market Size by Region 8.3.1 Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Region (2018-2027) 8.3.2 Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Lymphocyte Activation Gene 3 Protein Market Size by Type 9.1.1 Latin America Lymphocyte Activation Gene 3 Protein Sales by Type (2019-2027) 9.1.2 Latin America Lymphocyte Activation Gene 3 Protein Revenue by Type (2019-2027) 9.2 Latin America Lymphocyte Activation Gene 3 Protein Market Size by Application 9.2.1 Latin America Lymphocyte Activation Gene 3 Protein Sales by Application (2019-2027) 9.2.2 Latin America Lymphocyte Activation Gene 3 Protein Revenue by Application (2019-2027) 9.3 Latin America Lymphocyte Activation Gene 3 Protein Market Size by Country 9.3.1 Latin America Lymphocyte Activation Gene 3 Protein Sales by Country (2019-2027) 9.3.2 Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Lymphocyte Activation Gene 3 Protein Market Size by Type 6.1.1 Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2027) 6.1.2 Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2027) 6.2 Middle East and Africa Lymphocyte Activation Gene 3 Protein Market Size by Application 6.2.1 Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2027) 6.2.2 Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2027) 6.3 Middle East and Africa Lymphocyte Activation Gene 3 Protein Market Size by Country 6.3.1 Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2027) 6.3.2 Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Boehringer Ingelheim GmbH 11.1.1 Boehringer Ingelheim GmbH Corporation Information 11.1.2 Boehringer Ingelheim GmbH Overview 11.1.3 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product Description 11.1.5 Boehringer Ingelheim GmbH Related Developments 11.2 Bristol-Myers Squibb Company 11.2.1 Bristol-Myers Squibb Company Corporation Information 11.2.2 Bristol-Myers Squibb Company Overview 11.2.3 Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Product Description 11.2.5 Bristol-Myers Squibb Company Related Developments 11.3 Crescendo Biologics Ltd 11.3.1 Crescendo Biologics Ltd Corporation Information 11.3.2 Crescendo Biologics Ltd Overview 11.3.3 Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Product Description 11.3.5 Crescendo Biologics Ltd Related Developments 11.4 Enumeral Biomedical Holdings Inc 11.4.1 Enumeral Biomedical Holdings Inc Corporation Information 11.4.2 Enumeral Biomedical Holdings Inc Overview 11.4.3 Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Product Description 11.4.5 Enumeral Biomedical Holdings Inc Related Developments 11.5 GlaxoSmithKline Plc 11.5.1 GlaxoSmithKline Plc Corporation Information 11.5.2 GlaxoSmithKline Plc Overview 11.5.3 GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Product Description 11.5.5 GlaxoSmithKline Plc Related Developments 11.6 Icell Kealex Therapeutics 11.6.1 Icell Kealex Therapeutics Corporation Information 11.6.2 Icell Kealex Therapeutics Overview 11.6.3 Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Product Description 11.6.5 Icell Kealex Therapeutics Related Developments 11.7 Incyte Corp 11.7.1 Incyte Corp Corporation Information 11.7.2 Incyte Corp Overview 11.7.3 Incyte Corp Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Incyte Corp Lymphocyte Activation Gene 3 Protein Product Description 11.7.5 Incyte Corp Related Developments 11.8 MacroGenics Inc 11.8.1 MacroGenics Inc Corporation Information 11.8.2 MacroGenics Inc Overview 11.8.3 MacroGenics Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 MacroGenics Inc Lymphocyte Activation Gene 3 Protein Product Description 11.8.5 MacroGenics Inc Related Developments 11.9 Merck & Co Inc 11.9.1 Merck & Co Inc Corporation Information 11.9.2 Merck & Co Inc Overview 11.9.3 Merck & Co Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Merck & Co Inc Lymphocyte Activation Gene 3 Protein Product Description 11.9.5 Merck & Co Inc Related Developments 11.10 Novartis AG 11.10.1 Novartis AG Corporation Information 11.10.2 Novartis AG Overview 11.10.3 Novartis AG Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Novartis AG Lymphocyte Activation Gene 3 Protein Product Description 11.10.5 Novartis AG Related Developments 11.1 Boehringer Ingelheim GmbH 11.1.1 Boehringer Ingelheim GmbH Corporation Information 11.1.2 Boehringer Ingelheim GmbH Overview 11.1.3 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product Description 11.1.5 Boehringer Ingelheim GmbH Related Developments 11.12 Regeneron Pharmaceuticals Inc 11.12.1 Regeneron Pharmaceuticals Inc Corporation Information 11.12.2 Regeneron Pharmaceuticals Inc Overview 11.12.3 Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Regeneron Pharmaceuticals Inc Product Description 11.12.5 Regeneron Pharmaceuticals Inc Related Developments 11.13 Sutro Biopharma Inc 11.13.1 Sutro Biopharma Inc Corporation Information 11.13.2 Sutro Biopharma Inc Overview 11.13.3 Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Sutro Biopharma Inc Product Description 11.13.5 Sutro Biopharma Inc Related Developments 11.14 Symphogen A/S 11.14.1 Symphogen A/S Corporation Information 11.14.2 Symphogen A/S Overview 11.14.3 Symphogen A/S Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Symphogen A/S Product Description 11.14.5 Symphogen A/S Related Developments 11.15 Tesaro Inc 11.15.1 Tesaro Inc Corporation Information 11.15.2 Tesaro Inc Overview 11.15.3 Tesaro Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 Tesaro Inc Product Description 11.15.5 Tesaro Inc Related Developments 11.16 Trellis Bioscience Inc 11.16.1 Trellis Bioscience Inc Corporation Information 11.16.2 Trellis Bioscience Inc Overview 11.16.3 Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.16.4 Trellis Bioscience Inc Product Description 11.16.5 Trellis Bioscience Inc Related Developments 11.17 Xencor Inc 11.17.1 Xencor Inc Corporation Information 11.17.2 Xencor Inc Overview 11.17.3 Xencor Inc Lymphocyte Activation Gene 3 Protein Sales, Price, Revenue and Gross Margin (2016-2021) 11.17.4 Xencor Inc Product Description 11.17.5 Xencor Inc Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Lymphocyte Activation Gene 3 Protein Value Chain Analysis 12.2 Lymphocyte Activation Gene 3 Protein Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Lymphocyte Activation Gene 3 Protein Production Mode & Process 12.4 Lymphocyte Activation Gene 3 Protein Sales and Marketing 12.4.1 Lymphocyte Activation Gene 3 Protein Sales Channels 12.4.2 Lymphocyte Activation Gene 3 Protein Distributors 12.5 Lymphocyte Activation Gene 3 Protein Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Lymphocyte Activation Gene 3 Protein Industry Trends 13.2 Lymphocyte Activation Gene 3 Protein Market Drivers 13.3 Lymphocyte Activation Gene 3 Protein Market Challenges 13.4 Lymphocyte Activation Gene 3 Protein Market Restraints 14 Key Findings in The Global Lymphocyte Activation Gene 3 Protein Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Lymphocyte Activation Gene 3 Protein Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of BMS-986016 Table 3. Major Manufacturers of ENUM-006 Table 4. Major Manufacturers of IKT-203 Table 5. Major Manufacturers of IMP-701 Table 6. Major Manufacturers of Others Table 7. Global Lymphocyte Activation Gene 3 Protein Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Lymphocyte Activation Gene 3 Protein Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 9. Global Lymphocyte Activation Gene 3 Protein Sales by Region (2016-2021) & (K Pcs) Table 10. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2016-2021) Table 11. Global Lymphocyte Activation Gene 3 Protein Sales by Region (2016-2021) & (K Pcs) Table 12. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2022-2027) Table 13. Global Lymphocyte Activation Gene 3 Protein Revenue by Region (2016-2021) & (US$ Million) Table 14. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region (2016-2021) Table 15. Global Lymphocyte Activation Gene 3 Protein Revenue by Region (2022-2027) & (US$ Million) Table 16. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region (2022-2027) Table 17. Global Lymphocyte Activation Gene 3 Protein Sales by Manufacturers (2016-2021) & (K Pcs) Table 18. Global Lymphocyte Activation Gene 3 Protein Sales Share by Manufacturers (2016-2021) Table 19. Global Lymphocyte Activation Gene 3 Protein Revenue by Manufacturers (2016-2021) & (US$ Million) Table 20. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Manufacturers (2016-2021) Table 21. Lymphocyte Activation Gene 3 Protein Price by Manufacturers 2016-2021 (USD/Pcs) Table 22. Global Lymphocyte Activation Gene 3 Protein Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Global Lymphocyte Activation Gene 3 Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lymphocyte Activation Gene 3 Protein as of 2020) Table 24. Lymphocyte Activation Gene 3 Protein Manufacturing Base Distribution and Headquarters Table 25. Manufacturers Lymphocyte Activation Gene 3 Protein Product Offered Table 26. Date of Manufacturers Enter into Lymphocyte Activation Gene 3 Protein Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 29. Global Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 30. Global Lymphocyte Activation Gene 3 Protein Sales Share by Type (2016-2021) Table 31. Global Lymphocyte Activation Gene 3 Protein Sales Share by Type (2022-2027) Table 32. Global Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 33. Global Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 34. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Type (2016-2021) Table 35. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Type (2022-2027) Table 36. Lymphocyte Activation Gene 3 Protein Price by Type (2016-2021) & (USD/Pcs) Table 37. Global Lymphocyte Activation Gene 3 Protein Price Forecast by Type (2022-2027) & (USD/Pcs) Table 38. Global Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 39. Global Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 40. Global Lymphocyte Activation Gene 3 Protein Sales Share by Application (2016-2021) Table 41. Global Lymphocyte Activation Gene 3 Protein Sales Share by Application (2022-2027) Table 42. Global Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 43. Global Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 44. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Application (2016-2021) Table 45. Global Lymphocyte Activation Gene 3 Protein Revenue Share by Application (2022-2027) Table 46. Lymphocyte Activation Gene 3 Protein Price by Application (2016-2021) & (USD/Pcs) Table 47. Global Lymphocyte Activation Gene 3 Protein Price Forecast by Application (2022-2027) & (USD/Pcs) Table 48. North America Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 49. North America Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 50. North America Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 51. North America Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 52. North America Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 53. North America Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 54. North America Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 55. North America Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 56. North America Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2021) & (K Pcs) Table 57. North America Lymphocyte Activation Gene 3 Protein Sales by Country (2022-2027) & (K Pcs) Table 58. North America Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2021) & (US$ Million) Table 59. North America Lymphocyte Activation Gene 3 Protein Revenue by Country (2022-2027) & (US$ Million) Table 60. Europe Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 61. Europe Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 62. Europe Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 63. Europe Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 64. Europe Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 65. Europe Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 66. Europe Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 67. Europe Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 68. Europe Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2021) & (K Pcs) Table 69. Europe Lymphocyte Activation Gene 3 Protein Sales by Country (2022-2027) & (K Pcs) Table 70. Europe Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2021) & (US$ Million) Table 71. Europe Lymphocyte Activation Gene 3 Protein Revenue by Country (2022-2027) & (US$ Million) Table 72. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 73. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 74. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 75. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 76. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 77. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 78. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 79. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 80. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Region (2016-2021) & (K Pcs) Table 81. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales by Region (2022-2027) & (K Pcs) Table 82. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region (2016-2021) & (US$ Million) Table 83. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue by Region (2022-2027) & (US$ Million) Table 84. Latin America Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 85. Latin America Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 86. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 87. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 88. Latin America Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 89. Latin America Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 90. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 91. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 92. Latin America Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2021) & (K Pcs) Table 93. Latin America Lymphocyte Activation Gene 3 Protein Sales by Country (2022-2027) & (K Pcs) Table 94. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2021) & (US$ Million) Table 95. Latin America Lymphocyte Activation Gene 3 Protein Revenue by Country (2022-2027) & (US$ Million) Table 96. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Type (2016-2021) & (K Pcs) Table 97. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Type (2022-2027) & (K Pcs) Table 98. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Type (2016-2021) & (US$ Million) Table 99. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Type (2022-2027) & (US$ Million) Table 100. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Application (2016-2021) & (K Pcs) Table 101. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Application (2022-2027) & (K Pcs) Table 102. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Application (2016-2021) & (US$ Million) Table 103. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Application (2022-2027) & (US$ Million) Table 104. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Country (2016-2021) & (K Pcs) Table 105. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales by Country (2022-2027) & (K Pcs) Table 106. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country (2016-2021) & (US$ Million) Table 107. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue by Country (2022-2027) & (US$ Million) Table 108. Boehringer Ingelheim GmbH Corporation Information Table 109. Boehringer Ingelheim GmbH Description and Major Businesses Table 110. Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Boehringer Ingelheim GmbH Lymphocyte Activation Gene 3 Protein Product Table 112. Boehringer Ingelheim GmbH Recent Developments Table 113. Bristol-Myers Squibb Company Corporation Information Table 114. Bristol-Myers Squibb Company Description and Major Businesses Table 115. Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. Bristol-Myers Squibb Company Lymphocyte Activation Gene 3 Protein Product Table 117. Bristol-Myers Squibb Company Recent Developments Table 118. Crescendo Biologics Ltd Corporation Information Table 119. Crescendo Biologics Ltd Description and Major Businesses Table 120. Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. Crescendo Biologics Ltd Lymphocyte Activation Gene 3 Protein Product Table 122. Crescendo Biologics Ltd Recent Developments Table 123. Enumeral Biomedical Holdings Inc Corporation Information Table 124. Enumeral Biomedical Holdings Inc Description and Major Businesses Table 125. Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. Enumeral Biomedical Holdings Inc Lymphocyte Activation Gene 3 Protein Product Table 127. Enumeral Biomedical Holdings Inc Recent Developments Table 128. GlaxoSmithKline Plc Corporation Information Table 129. GlaxoSmithKline Plc Description and Major Businesses Table 130. GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. GlaxoSmithKline Plc Lymphocyte Activation Gene 3 Protein Product Table 132. GlaxoSmithKline Plc Recent Developments Table 133. Icell Kealex Therapeutics Corporation Information Table 134. Icell Kealex Therapeutics Description and Major Businesses Table 135. Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. Icell Kealex Therapeutics Lymphocyte Activation Gene 3 Protein Product Table 137. Icell Kealex Therapeutics Recent Developments Table 138. Incyte Corp Corporation Information Table 139. Incyte Corp Description and Major Businesses Table 140. Incyte Corp Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 141. Incyte Corp Lymphocyte Activation Gene 3 Protein Product Table 142. Incyte Corp Recent Developments Table 143. MacroGenics Inc Corporation Information Table 144. MacroGenics Inc Description and Major Businesses Table 145. MacroGenics Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 146. MacroGenics Inc Lymphocyte Activation Gene 3 Protein Product Table 147. MacroGenics Inc Recent Developments Table 148. Merck & Co Inc Corporation Information Table 149. Merck & Co Inc Description and Major Businesses Table 150. Merck & Co Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 151. Merck & Co Inc Lymphocyte Activation Gene 3 Protein Product Table 152. Merck & Co Inc Recent Developments Table 153. Novartis AG Corporation Information Table 154. Novartis AG Description and Major Businesses Table 155. Novartis AG Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 156. Novartis AG Lymphocyte Activation Gene 3 Protein Product Table 157. Novartis AG Recent Developments Table 158. Prima BioMed Ltd Corporation Information Table 159. Prima BioMed Ltd Description and Major Businesses Table 160. Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 161. Prima BioMed Ltd Lymphocyte Activation Gene 3 Protein Product Table 162. Prima BioMed Ltd Recent Developments Table 163. Regeneron Pharmaceuticals Inc Corporation Information Table 164. Regeneron Pharmaceuticals Inc Description and Major Businesses Table 165. Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 166. Regeneron Pharmaceuticals Inc Lymphocyte Activation Gene 3 Protein Product Table 167. Regeneron Pharmaceuticals Inc Recent Developments Table 168. Sutro Biopharma Inc Corporation Information Table 169. Sutro Biopharma Inc Description and Major Businesses Table 170. Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 171. Sutro Biopharma Inc Lymphocyte Activation Gene 3 Protein Product Table 172. Sutro Biopharma Inc Recent Developments Table 173. Symphogen A/S Corporation Information Table 174. Symphogen A/S Description and Major Businesses Table 175. Symphogen A/S Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 176. Symphogen A/S Lymphocyte Activation Gene 3 Protein Product Table 177. Symphogen A/S Recent Developments Table 178. Tesaro Inc Corporation Information Table 179. Tesaro Inc Description and Major Businesses Table 180. Tesaro Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 181. Tesaro Inc Lymphocyte Activation Gene 3 Protein Product Table 182. Tesaro Inc Recent Developments Table 183. Trellis Bioscience Inc Corporation Information Table 184. Trellis Bioscience Inc Description and Major Businesses Table 185. Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 186. Trellis Bioscience Inc Lymphocyte Activation Gene 3 Protein Product Table 187. Trellis Bioscience Inc Recent Developments Table 188. Xencor Inc Corporation Information Table 189. Xencor Inc Description and Major Businesses Table 190. Xencor Inc Lymphocyte Activation Gene 3 Protein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 191. Xencor Inc Lymphocyte Activation Gene 3 Protein Product Table 192. Xencor Inc Recent Developments Table 193. Key Raw Materials Lists Table 194. Raw Materials Key Suppliers Lists Table 195. Lymphocyte Activation Gene 3 Protein Distributors List Table 196. Lymphocyte Activation Gene 3 Protein Customers List Table 197. Lymphocyte Activation Gene 3 Protein Market Trends Table 198. Lymphocyte Activation Gene 3 Protein Market Drivers Table 199. Lymphocyte Activation Gene 3 Protein Market Challenges Table 200. Lymphocyte Activation Gene 3 Protein Market Restraints Table 201. Research Programs/Design for This Report Table 202. Key Data Information from Secondary Sources Table 203. Key Data Information from Primary Sources List of Figures Figure 1. Lymphocyte Activation Gene 3 Protein Product Picture Figure 2. Global Lymphocyte Activation Gene 3 Protein Market Share by Type in 2020 & 2027 Figure 3. BMS-986016 Product Picture Figure 4. ENUM-006 Product Picture Figure 5. IKT-203 Product Picture Figure 6. IMP-701 Product Picture Figure 7. Others Product Picture Figure 8. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Application in 2020 & 2027 Figure 9. Chronic Inflammation Figure 10. Head and Neck Cancer Squamous Cell Carcinoma Figure 11. Kidney Cancer Figure 12. Others Figure 13. Lymphocyte Activation Gene 3 Protein Report Years Considered Figure 14. Global Lymphocyte Activation Gene 3 Protein Sales 2016-2027 (K Pcs) Figure 15. Global Lymphocyte Activation Gene 3 Protein Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Lymphocyte Activation Gene 3 Protein Revenue 2016-2027 (US$ Million) Figure 17. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 18. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2016-2021) Figure 19. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Region (2022-2027) Figure 20. North America Lymphocyte Activation Gene 3 Protein Sales YoY (2016-2027) & (K Pcs) Figure 21. North America Lymphocyte Activation Gene 3 Protein Revenue YoY (2016-2027) & (US$ Million) Figure 22. Europe Lymphocyte Activation Gene 3 Protein Sales YoY (2016-2027) & (K Pcs) Figure 23. Europe Lymphocyte Activation Gene 3 Protein Revenue YoY (2016-2027) & (US$ Million) Figure 24. Asia-Pacific Lymphocyte Activation Gene 3 Protein Sales YoY (2016-2027) & (K Pcs) Figure 25. Asia-Pacific Lymphocyte Activation Gene 3 Protein Revenue YoY (2016-2027) & (US$ Million) Figure 26. Latin America Lymphocyte Activation Gene 3 Protein Sales YoY (2016-2027) & (K Pcs) Figure 27. Latin America Lymphocyte Activation Gene 3 Protein Revenue YoY (2016-2027) & (US$ Million) Figure 28. Middle East & Africa Lymphocyte Activation Gene 3 Protein Sales YoY (2016-2027) & (K Pcs) Figure 29. Middle East & Africa Lymphocyte Activation Gene 3 Protein Revenue YoY (2016-2027) & (US$ Million) Figure 30. The Top 10 and Top 5 Players Market Share by Lymphocyte Activation Gene 3 Protein Sales in 2020 Figure 31. The Top 10 and Top 5 Players Market Share by Lymphocyte Activation Gene 3 Protein Revenue in 2020 Figure 32. Lymphocyte Activation Gene 3 Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 34. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 35. Global Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 36. Global Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 37. North America Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 38. North America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 39. North America Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 40. North America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 41. North America Lymphocyte Activation Gene 3 Protein Sales Share by Country (2016-2027) Figure 42. North America Lymphocyte Activation Gene 3 Protein Revenue Share by Country (2016-2027) Figure 43. U.S. Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 44. Canada Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 45. Europe Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 46. Europe Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 47. Europe Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 48. Europe Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 49. Europe Lymphocyte Activation Gene 3 Protein Sales Share by Country (2016-2027) Figure 50. Europe Lymphocyte Activation Gene 3 Protein Revenue Share by Country (2016-2027) Figure 51. Germany Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 52. France Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 53. U.K. Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 54. Italy Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 55. Russia Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 56. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 57. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 58. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 59. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 60. Asia Pacific Lymphocyte Activation Gene 3 Protein Sales Share by Region (2016-2027) Figure 61. Asia Pacific Lymphocyte Activation Gene 3 Protein Revenue Share by Region (2016-2027) Figure 62. China Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 63. Japan Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 64. South Korea Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 65. India Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 66. Australia Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 67. Taiwan Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 68. Indonesia Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 69. Thailand Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 70. Malaysia Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 71. Philippines Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 72. Latin America Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 73. Latin America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 74. Latin America Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 75. Latin America Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 76. Latin America Lymphocyte Activation Gene 3 Protein Sales Share by Country (2016-2027) Figure 77. Latin America Lymphocyte Activation Gene 3 Protein Revenue Share by Country (2016-2027) Figure 78. Mexico Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 79. Brazil Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 80. Argentina Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 81. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales Market Share by Type (2016-2027) Figure 82. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue Market Share by Type (2016-2027) Figure 83. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales Market Share by Application (2016-2027) Figure 84. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue Market Share by Application (2016-2027) Figure 85. Middle East and Africa Lymphocyte Activation Gene 3 Protein Sales Share by Country (2016-2027) Figure 86. Middle East and Africa Lymphocyte Activation Gene 3 Protein Revenue Share by Country (2016-2027) Figure 87. Turkey Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 88. Saudi Arabia Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 89. U.A.E Lymphocyte Activation Gene 3 Protein Revenue (2016-2027) & (US$ Million) Figure 90. Lymphocyte Activation Gene 3 Protein Value Chain Figure 91. Lymphocyte Activation Gene 3 Protein Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Boehringer Ingelheim GmbH Bristol-Myers Squibb Company Crescendo Biologics Ltd Enumeral Biomedical Holdings Inc GlaxoSmithKline Plc Icell Kealex Therapeutics Incyte Corp MacroGenics Inc Merck & Co Inc Novartis AG Prima BioMed Ltd Regeneron Pharmaceuticals Inc Sutro Biopharma Inc Symphogen A/S Tesaro Inc Trellis Bioscience Inc Xencor Inc